switching from compounded semaglutide to tirzepatide vs Tirzepatide: Which Is Better for Weight Loss? Switching from Semaglutide to Tirzepetide

Clinical trials with GLP-1 medications show that people typically regain a significant proportion of lost weight within a year of stopping, without ongoing support

Why is high Lp(a) a problem: The epidemiological studies on lipoprotein(a) have shown for decades that high Lp(a) increases the risk of cardiovascular disease

Patients in the GSH group were significantly less likely to discontinue treatment due to kidney issues (P = 0.012)

The results of this study support the hypothesis that SGLT2i and GLP1-ra may have a beneficial role in preventing the development of DMO in individuals with type 2 diabetes taking insulin, but due to the study design they do not establish a causal link